By systematically evaluating their physicochemical properties, photothermal conversion efficiency, targeting specificity, in vitro cytotoxicity, in vivo therapeutic efficacy, and biosafety, we demonstrate that PSMA-OSP12 NPs provide not only precise tumor ablation but also potential immunoregulatory benefits. Here, FOLH1 is linked to neoplasm.